Full-Time
Principal Statistician
Pharmacokinetics
PSI CRO
1,001-5,000 employees
Global CRO delivering on-time patient enrollment
No salary listed
Paris, France
Remote
 Biology & Biotech (2) |
|---|
| , |
Get referred to PSI CRO
See people who can refer or advise you
- MSc in Statistics or equivalent
- Full working proficiency in English
- Expert knowledge and understanding of the statistical principles, concepts, methods, and standards used in clinical research
- Expert knowledge and understanding of the SAS programming
- Expert knowledge and understanding of CDISC ADaM standard
- Expert knowledge and understanding of pharmacokinetics principles, concepts, methods and standards used in clinical research, including the conduct NCL and population PK analysis
- Expert knowledge and understanding of Phoenix WinNonlin and NLME
- Expert knowledge and understanding of relevant regulations and guidelines (e.g. FDA, EMA, ICH)
- Ability to apply a range of advanced statistical techniques in support of clinical research studies and to analyze, interpret, and draw conclusions from complex statistical information
- Ability to consult with clinical investigators, interpret research requirements, and determine statistical analysis strategies
- Strong presentation and communication skills
- Act as a communication line for project teams, clients, vendors and internal team on statistical questions
- Conduct statistical analysis for clinical trials including, interim analysis, final analysis, analysis for DSMBs/DMCs and PK analysis
- Develop and review study protocols, statistical analysis plans, analysis dataset specifications according to CDISC ADaM standard and other project-specific documents
- Review statistical deliverables such as tables, figures, listings and analysis datasets
- Conduct departmental induction course and project-specific training for statisticians and SAS programmers
- Prepare for and attend internal and external study audits pertinent to Statistics
- Participate in preparation of internal/external audits follow up
- Provide input to standard operating procedures and other Quality Systems Documents (QSDs) pertinent to activities of Biostatistics
- Liaise with DM on statistical questions related to data issues
- Participate in bid defense and in kick-off meetings
- Lead teams of SAS programmers and/or statisticians on the project level
PSI CRO is a global contract research organization that handles clinical trials for multiple therapeutic areas, with a focus on enrolling patients on schedule and delivering studies on time. Its services span feasibility assessments, trial planning, site selection, patient recruitment, and multi-continent trial execution across 50+ countries, backed by medical doctor resources dedicated to accurate timeline predictions. Unlike many CROs, PSI emphasizes predictable enrollment and on-time project delivery, aiming for high client satisfaction and repeat business through a pragmatic, no-nonsense approach. The company’s goal is to be regarded as the best CRO in the world by both clients and employees, achieved through reliable timelines, strong execution, and low staff turnover.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Switzerland
Founded
1995
Get referred to PSI CRO
See people who can refer or advise you
Simplify's Take
What believers are saying
- Beijing improves proximity to Chinese regulators and investigator sites.
- Toronto expansion supports North American phase II and III growth.
- Japan leadership strengthens local execution across Asia-Pacific.
What critics are saying
- China operations face tighter oversight, data-access limits, and policy shifts.
- AI site selection depends on fragmented data quality and sponsor trust.
- New offices raise fixed costs before revenue catches up.
What makes PSI CRO unique
- Swiss-based CRO with a growing China presence in Shanghai and Beijing.
- SYNETIC cuts trial site identification from weeks to minutes.
- Global full-service execution spans 50+ countries across planning through delivery.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Paid Vacation
Flexible Work Hours
Hybrid Work Options
Remote Work Options
Wellness Program
Mental Health Support
Conference Attendance Budget
Professional Development Budget
Company News
PSI CRO, a global clinical research organisation, has reduced clinical trial site identification from up to six weeks to minutes using SYNETIC, an AI knowledge engine powered by the Arango Contextual Data Platform. The system helps identify higher-performing trial sites and minimise costly non-enrolling institutions, which account for 30-40% of trial sites. Clinical trials can cost over $160 per minute operationally, and activating a trial site costs $30,000 or more. With 15% of sites never enrolling a single patient, failed recruitment can cost millions per study. SYNETIC unifies fragmented clinical research data into a single contextual layer, preserving relationships across investigators, institutions, protocols and historical outcomes. The platform provides explainable AI recommendations, including rationale, supporting evidence and confidence levels, enabling data-driven site selection in minutes rather than weeks.
PSI CRO strengthens Canadian presence with new Toronto office and leadership role. PSI CRO has broadened its footprint in Canada by opening a new office in the Toronto area and naming an experienced industry leader to guide its operations there. The office, located in Mississauga, Ontario, builds on the company's established Canadian presence and commitment to clinical research excellence. PSI CRO has been active in Canada for over a decade, supporting complex clinical trials with a focus on dependable delivery and strong relationships with research sites. As part of this expansion, David Allen, MBA, has been appointed as Country Manager for Canada. Allen brings more than 30 years of experience in clinical research from both sponsor and CRO environments. In his new role, he will lead efforts to enhance the company's operational capabilities in the local market and ensure alignment with PSI's global standards for on-time trial execution. PSI's continued growth in North America reflects broader trends of increasing trial activity in the region, particularly for pivotal phase II and phase III studies where precision and efficiency are critical. The expanded Toronto operations aim to further support sponsors with rigorous trial planning and execution.
TOKYO, 14 March 2025 - PSI CRO AG, a global Swiss-based clinical research organization (CRO), is pleased to announce the appointment of Sayaka Kaji as Country Manager for Japan.
Psi CRO Ag launched a CRA Academy to provide to help its team members develop therapeutic expertise as well as soft skills to manage key relationships with sites.
This is also the fourth year in a row in which PSI CRO received CRO Leadership Awards in all five categories, also including Expertise and Capabilities, across two respondent groups.